Correlation Between Qualigen Therapeutics and Appen

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Qualigen Therapeutics and Appen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Qualigen Therapeutics and Appen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Qualigen Therapeutics and Appen Limited, you can compare the effects of market volatilities on Qualigen Therapeutics and Appen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Qualigen Therapeutics with a short position of Appen. Check out your portfolio center. Please also check ongoing floating volatility patterns of Qualigen Therapeutics and Appen.

Diversification Opportunities for Qualigen Therapeutics and Appen

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Qualigen and Appen is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Qualigen Therapeutics and Appen Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Appen Limited and Qualigen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Qualigen Therapeutics are associated (or correlated) with Appen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Appen Limited has no effect on the direction of Qualigen Therapeutics i.e., Qualigen Therapeutics and Appen go up and down completely randomly.

Pair Corralation between Qualigen Therapeutics and Appen

Given the investment horizon of 90 days Qualigen Therapeutics is expected to under-perform the Appen. But the stock apears to be less risky and, when comparing its historical volatility, Qualigen Therapeutics is 1.45 times less risky than Appen. The stock trades about -0.04 of its potential returns per unit of risk. The Appen Limited is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest  43.00  in Appen Limited on November 9, 2024 and sell it today you would earn a total of  112.00  from holding Appen Limited or generate 260.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy98.52%
ValuesDaily Returns

Qualigen Therapeutics  vs.  Appen Limited

 Performance 
       Timeline  
Qualigen Therapeutics 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Qualigen Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.
Appen Limited 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Appen Limited are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak technical and fundamental indicators, Appen reported solid returns over the last few months and may actually be approaching a breakup point.

Qualigen Therapeutics and Appen Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Qualigen Therapeutics and Appen

The main advantage of trading using opposite Qualigen Therapeutics and Appen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Qualigen Therapeutics position performs unexpectedly, Appen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Appen will offset losses from the drop in Appen's long position.
The idea behind Qualigen Therapeutics and Appen Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Fundamental Analysis
View fundamental data based on most recent published financial statements
CEOs Directory
Screen CEOs from public companies around the world
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum